Parkside Financial Bank & Trust’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $97K | Buy |
1,545
+45
| +3% | +$3.13K | 0.01% | 694 |
|
|
2025
Q4 | $99.6K | Sell |
1,500
-123
| -8% | -$7.95K | 0.01% | 696 |
|
|
2025
Q3 | $109K | Sell |
1,623
-236
| -13% | -$18.7K | 0.01% | 637 |
|
|
2025
Q2 | $162K | Sell |
1,859
-187
| -9% | -$14.7K | 0.02% | 484 |
|
|
2025
Q1 | $140K | Buy |
2,046
+37
| +2% | +$3.02K | 0.02% | 470 |
|
|
2024
Q4 | $156K | Buy |
2,009
+325
| +19% | +$24.1K | 0.02% | 442 |
|
|
2024
Q3 | $113K | Sell |
1,684
-622
| -27% | -$51.1K | 0.02% | 513 |
|
|
2024
Q2 | $261K | Buy |
2,306
+12
| +0.5% | +$1.52K | 0.04% | 296 |
|
|
2024
Q1 | $318K | Buy |
2,294
+208
| +10% | +$26.1K | 0.05% | 267 |
|
|
2023
Q4 | $259K | Buy |
2,086
+218
| +12% | +$22.3K | 0.05% | 263 |
|
|
2023
Q3 | $174K | Hold |
1,868
| – | – | 0.04% | 287 |
|
|
2023
Q2 | $240K | Buy |
1,868
+103
| +6% | +$12.5K | 0.06% | 230 |
|
|
2023
Q1 | $205K | Buy |
1,765
+7
| +0.4% | +$784 | 0.06% | 232 |
|
|
2022
Q4 | $199K | Buy |
1,758
+286
| +19% | +$31.4K | 0.06% | 227 |
|
|
2022
Q3 | $119K | Sell |
1,472
-69
| -4% | -$5.84K | 0.04% | 301 |
|
|
2022
Q2 | $114K | Buy |
1,541
+961
| +166% | +$87.7K | 0.03% | 305 |
|
|
2022
Q1 | $74K | Buy |
580
+16
| +3% | +$1.75K | 0.02% | 420 |
|
|
2021
Q4 | $75K | Buy |
564
+120
| +27% | +$17.2K | 0.02% | 422 |
|
|
2021
Q3 | $61K | Buy |
444
+184
| +71% | +$23.2K | 0.02% | 448 |
|
|
2021
Q2 | $28K | Buy |
260
+152
| +141% | +$14.6K | 0.01% | 670 |
|
|
2021
Q1 | $10K | Buy |
108
+36
| +50% | +$3.38K | ﹤0.01% | 925 |
|
|
2020
Q4 | $6K | Sell |
72
-332
| -82% | -$29.6K | ﹤0.01% | 1030 |
|
|
2020
Q3 | $42K | Buy |
404
+4
| +1% | +$418 | 0.01% | 446 |
|
|
2020
Q2 | $41K | Sell |
400
-152
| -28% | -$13.6K | 0.01% | 465 |
|
|
2020
Q1 | $37K | Sell |
552
-220
| -28% | -$13.7K | 0.01% | 424 |
|
|
2019
Q4 | $42K | Buy |
772
+76
| +11% | +$3.6K | 0.01% | 467 |
|
|
2019
Q3 | $26K | Buy |
696
+64
| +10% | +$2.49K | 0.01% | 549 |
|
|
2019
Q2 | $24K | Hold |
632
| – | – | 0.01% | 579 |
|
|
2019
Q1 | $19K | Sell |
632
-64
| -9% | -$2.25K | 0.01% | 619 |
|
|
2018
Q4 | $21K | Buy |
696
+64
| +10% | +$2.03K | 0.01% | 551 |
|
|
2018
Q3 | $23K | Hold |
632
| – | – | 0.01% | 564 |
|
|
2018
Q2 | $15K | Buy |
632
+368
| +139% | +$7.8K | 0.01% | 656 |
|
|
2018
Q1 | $5K | Buy |
+264
| New | +$3.9K | ﹤0.01% | 843 |
|
|
2017
Q3 | – | Sell |
-568
| Closed | -$10K | – | 1412 |
|
|
2017
Q2 | $10K | Sell |
568
-264
| -32% | -$4.88K | ﹤0.01% | 736 |
|
|
2017
Q1 | $18K | Buy |
832
+232
| +39% | +$4.53K | 0.01% | 556 |
|
|
2016
Q4 | $9K | Sell |
600
-192
| -24% | -$3.4K | ﹤0.01% | 723 |
|
|
2016
Q3 | $17K | Sell |
792
-56
| -7% | -$1.25K | 0.01% | 602 |
|
|
2016
Q2 | $17K | Buy |
848
+160
| +23% | +$2.72K | 0.01% | 572 |
|
|
2016
Q1 | $12K | Buy |
688
+260
| +61% | +$4.34K | 0.01% | 620 |
|
|
2015
Q4 | $9K | Buy |
428
+276
| +182% | +$5.74K | ﹤0.01% | 672 |
|
|
2015
Q3 | $3K | Buy |
+152
| New | +$3.39K | ﹤0.01% | 843 |
|
Other funds holding DXCM
VCM
VPM
Parkside Financial Bank & Trust's DXCM Position: Q1 2026 in Review
Parkside Financial Bank & Trust increased its DexCom (DXCM) stake by 3% in Q1 2026, buying an estimated $3.13K and bringing the position to 1,545 shares worth $97K. The position accounts for 0.01% of the portfolio, ranked #694.
Parkside Financial Bank & Trust first reported a position in DXCM in Q3 2015 and has held it in 41 quarters since. The position peaked at $318K in Q1 2024. 959 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Parkside Financial Bank & Trust held 1,545 shares of DexCom worth $97K as of Q1 2026.
- Parkside Financial Bank & Trust bought 45 DexCom shares in Q1 2026, an estimated $3.13K.
- DexCom made up 0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #694 holding.
- Parkside Financial Bank & Trust first reported a position in DexCom in Q3 2015 and has held it in 41 quarters since.
- Parkside Financial Bank & Trust's DexCom position peaked at $318K in Q1 2024.
- 959 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.